Kalos Therapeutics, Inc., Oncology Pharmaceuticals and NanoSmart Pharmaceuticals, Inc., Combination Therapy Offers the Potential of a Safer and More Effective Approach to a Wide Variety of Cancer Treatments
30 sept. 2019 06h30 HE
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH) is pleased to announce that Kalos Therapeutics' lead compound, KTH-222, can produce a reduction...
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19 août 2019 08h24 HE
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH)is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ)...
Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide Licence and Co-Devlopent of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19 août 2019 08h00 HE
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH) is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ)...
Oncology Pharma Appoints Stefan Gruenwald (MD. Ph.D) as an Advisor on its Advisory Board
15 juil. 2019 07h30 HE
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma, Inc. (OTCPK: ONPH) is pleased and honored to announce the appointment of Stefan Gruenwald (MD. Ph.D) to its...
SourcingLink.net Announces Corporate Name Change to Oncology Pharma, Inc.
17 juin 2019 08h30 HE
|
Oncology Pharma, Inc.
New Name Reflects the Company's Core Business of Oncology Therapeutics SAN FRANCISCO, CA, June 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SourcingLink.net, Inc. has announced that it has...
Veterinary Oncology Licensing Agreement Signed Between SourcingLink.net and NanoSmart Pharmaceuticals, Inc.
03 avr. 2019 07h00 HE
|
SourcingLink.net, Inc.
San Francisco, CA, April 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net, Inc. (SNET), a San Francisco, CA based company, announced today that it entered into an exclusive,...
SourcingLink.net Enters into an Exclusive Worldwide Licensing Agreement with NanoSmart Pharmaceuticals for Anti-Nuclear Antibody (ANA)-Targeted Doxorubicin Formulations to Treat Cancer
25 mars 2019 07h30 HE
|
SourcingLink.net, Inc.
SAN FRANCISCO, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SourcingLink.net, Inc. (SNET), announced today that it entered into an exclusive worldwide licensing agreement with NanoSmart...
SourcingLink.net Signs a Letter of Intent with NanoSmart Pharmaceuticals, Inc. for a Licensee and Co-Development Collaboration of NanoSmart's Proprietary Targeted Drug Delivery System for Cancer Drugs
26 févr. 2019 16h00 HE
|
SourcingLink.net, Inc.
San Francisco, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET), an early stage oncology company, is a pioneering company based in San Francisco,...
SourcingLink.net to Investigate the Potential of Combining its Novel Autologous Immune-Therapy with Synergistic Oncology Therapies
12 févr. 2019 16h00 HE
|
SourcingLink.net, Inc.
San Francisco, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET), based in San Francisco, is a pioneering biotech company focused on oncology . The company...
SourcingLink.net to Leverage Pharmacogenomics in Its Oncology Therapy Development and Clinical Trial Program
05 févr. 2019 08h30 HE
|
SourcingLink.net, Inc.
San Francisco, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET) is announcing that it will harness the power of pharmacogenomics in its oncology therapy...